Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IKFE (Institut für klinische Forschung und Entwicklung) is a specialized Contract Research Organization (CRO) based in Mainz, Germany, focusing on clinical trials for diabetes and metabolic diseases. Founded in 1997, the institute provides comprehensive services for Phase I-IV clinical trials, including study design, patient recruitment, and data management. IKFE is particularly recognized for its scientific expertise in glucose clamping techniques and the evaluation of insulin analogues and medical devices such as continuous glucose monitors. The company serves a global clientele of pharmaceutical and biotechnology firms, contributing to the advancement of innovative therapies for metabolic disorders. Its facilities are equipped to handle complex metabolic studies requiring high precision and specialized medical oversight. The institute's leadership is deeply involved in academic research, often collaborating with university hospitals on metabolic studies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ikfe.